Today is shaping up negative for Silence Therapeutics plc ( NASDAQ:SLN ) shareholders, with the analysts delivering a... LONDON, March 05, 2025--Silence Therapeutics plc, Nasdaq: SLN ("Silence" or ...
At close: March 14 at 4:00:00 PM EDT Loading Chart for SLN ...
Stay updated on market trends for SLN. Silence Therapeutics' Phase 2 data shows zerlasiran achieves over 80% Lp(a) reduction in ASCVD patients but faces dosing frequency challenges.
You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.
You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback